Pascal Bonnabry
Pascal Bonnabry
Geneva University Hospitals
Adresse e-mail validée de hcuge.ch - Page d'accueil
Titre
Citée par
Citée par
Année
Analysis of anticancer drugs: a review
S Nussbaumer, P Bonnabry, JL Veuthey, S Fleury-Souverain
Talanta 85 (5), 2265-2289, 2011
3352011
Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa
MN Chraiti, FM Sokona, A Gayet-Ageron, P Bonnabry
Infection control and hospital epidemiology 31 (2), 133-141, 2010
2102010
Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile
N Vernaz, H Sax, D Pittet, P Bonnabry, J Schrenzel, S Harbarth
Journal of Antimicrobial Chemotherapy 62 (3), 601-607, 2008
1722008
Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions
P Bonnabry, L Cingria, F Sadeghipour, H Ing, C Fonzo-Christe, RE Pfister
BMJ Quality & Safety 14 (2), 93-98, 2005
1442005
A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety
P Bonnabry, C Despont-Gros, D Grauser, P Casez, M Despond, D Pugin, ...
Journal of the American Medical Informatics Association 15 (4), 453-460, 2008
1312008
Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process
P Bonnabry, L Cingria, M Ackermann, F Sadeghipour, L Bigler, N Mach
International Journal for Quality in Health Care 18 (1), 9-16, 2006
1252006
A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs.
TD Leemann, C Transon, P Bonnabry, P Dayer
Drugs under experimental and clinical research 19 (5), 189-195, 1993
1131993
Use of transdermal drug formulations in the elderly
LZ Kaestli, AF Wasilewski-Rasca, P Bonnabry, N Vogt-Ferrier
Drugs & aging 25 (4), 269-280, 2008
922008
Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review
C Fonzo-Christe, C Vukasovic, AF Wasilewski-Rasca, P Bonnabry
Palliative medicine 19 (3), 208-219, 2005
912005
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community
N Vernaz, B Huttner, D Muscionico, JL Salomon, P Bonnabry, ...
Journal of Antimicrobial Chemotherapy 66 (4), 928-935, 2011
902011
Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines
RD Marini, E Rozet, MLA Montes, C Rohrbasser, S Roht, D Rhème, ...
Journal of pharmaceutical and biomedical analysis 53 (5), 1278-1287, 2010
822010
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam
P Bonnabry, T Leemann, P Dayer
European journal of clinical pharmacology 49 (4), 305-308, 1996
751996
Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality
C StuCki, AAMAA SAutter, JC FAvet, P BonnABry
American Journal of Health-System Pharmacy 66 (22), 2032-2036, 2009
722009
Measuring human-error probabilities in drug preparation: a pilot simulation study
P Garnerin, B Pellet-Meier, P Chopard, T Perneger, P Bonnabry
European journal of clinical pharmacology 63 (8), 769-776, 2007
562007
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
N Vernaz, G Haller, F Girardin, B Huttner, C Combescure, P Dayer, ...
PLoS Med 10 (6), e1001460, 2013
502013
Risk and pharmacoeconomic analyses of the injectable medication process in the paediatric and neonatal intensive care units
I De Giorgi, C Fonzo-Christe, L Cingria, B Caredda, V Meyer, RE Pfister, ...
International journal for quality in health care 22 (3), 170-178, 2010
502010
Wipe sampling procedure coupled to LC–MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces
S Nussbaumer, L Geiser, F Sadeghipour, D Hochstrasser, P Bonnabry, ...
Analytical and bioanalytical chemistry 402 (8), 2499-2509, 2012
472012
Simultaneous quantification of ten cytotoxic drugs by a validated LC–ESI–MS/MS method
S Nussbaumer, S Fleury-Souverain, P Antinori, F Sadeghipour, ...
Analytical and bioanalytical chemistry 398 (7-8), 3033-3042, 2010
432010
Temporal effects of antibiotic use and Clostridium difficile infections
N Vernaz, K Hill, S Leggeat, D Nathwani, G Philips, P Bonnabry, P Davey
Journal of antimicrobial chemotherapy 63 (6), 1272-1275, 2009
432009
Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation
L Bouchoud, C Fonzo‐Christe, M Klingmüller, P Bonnabry
Journal of Parenteral and Enteral Nutrition 37 (3), 416-424, 2013
412013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20